Skip to Content
Contact DCTD
Show menu
Search this site
Last Updated: 01/29/2018

Partnerships


The NCI Formulary
Provides NCI-funded main-member ETCTN and NCTN investigators with rapid access to cancer agents for research through a public-private partnership between the NCI and pharmaceutical and biotechnology companies.

NCTN/NCORP Data Archive
In partnership with Project Data Sphere, External Link provides a centralized, controlled-access database for storing and sharing datasets generated from clinical trials of the NCTN.


Partnerships with the Foundation for the National Institutes of Health (FNIH)

  • Partnership for Accelerating Cancer Therapies (PACT)
    In partnership with 11 pharmaceutical companies, facilitates clinical testing of biomarkers to accelerate our understanding of the mechanisms of response and resistance to cancer therapy. Four Cancer Immune Monitoring and Analysis Centers (CIMACs) and a Cancer Immunologic Data Commons (CIDC) will form a network of laboratory centers that will support both adult and pediatric immunotherapy trials.
  • Lung-MAP
    Uses a multi-drug, targeted screening approach to match patients with squamous cell lung cancer to sub-studies testing investigational new treatments based on their unique tumor profiles. View the Lung-MAP website.
  • The Biomarker Consortium
    Endeavors to discover, develop, and seek regulatory approval for biomarkers to support new drug development, preventive medicine, and medical diagnostics.